Cart
sales@molnova.com
Methyl palmitoleate
CAS No. 1120-25-8
Methyl palmitoleate( —— )
Catalog No. M21476 CAS No. 1120-25-8
Palmitoleic acid methyl ester is an ester version of palmitoleic acid an ω-7 monounsaturated fatty acid that is a common constituent of the triglycerides of human adipose tissue.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 26 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMethyl palmitoleate
-
NoteResearch use only, not for human use.
-
Brief DescriptionPalmitoleic acid methyl ester is an ester version of palmitoleic acid an ω-7 monounsaturated fatty acid that is a common constituent of the triglycerides of human adipose tissue.
-
DescriptionPalmitoleic acid methyl ester is an ester version of palmitoleic acid an ω-7 monounsaturated fatty acid that is a common constituent of the triglycerides of human adipose tissue.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1120-25-8
-
Formula Weight268.4
-
Molecular FormulaC17H32O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:30mg/ml(111.77mM)
-
SMILESCCCCCC/C=C\CCCCCCCC(OC)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nestel P. et al. Effects of increasing dietary palmitoleic acid compared with palmitic and oleic acids on plasma lipids of hypercholesterolemic men. J. Lipid Res. 35(4) 656-662 (1994).
molnova catalog
related products
-
CINPA1
CINPA1 is a selective inhibitor of constitutive androstane receptor (CAR) with an IC50 of 70 nM for CAR-mediated transcription. CINPA1 can be used in studies about CAR function.
-
SRT3109
SRT3109 is a CXCR2 ligand used in the treatment of chemokine mediated diseases and conditions.
-
Cyanidin-3,5-O-diglu...
Cyanidin-3,5-O-diglucoside chloride has antioxidant activity. Cyanidin-3,5-O-diglucoside inhibits hyperbaric pressure-induced GLAST decrease and can be used in glaucoma studies.
